对于社保基金，本期较上一季度持股减少的社保基金共计1个，即广发基金管理有限公司-社保基金四二 零组合，，持股减少占比达0.10%。本期较上一季未再披露的社保基金共计1个，即全国社保基金四一 三组合。 外资态度来看，本期较上一季度新披露的外资机构有 1 家 ，即香港中央结算有限公司。 公募基金方面，本期较上一期持股增加的公募基金共计1个，即工银专精特新混合A，持股增加占比小 幅上涨。本期较上一季度持股减少的公募基金共计9个，主要包括天弘永利债券A、天弘增强回报A、天 弘永利优佳混合A、广发睿升混合A、光大保德信专精特新混合A等，持股减少占比达1.66%。本期较上 一季度新披露的公募基金共计119个，主要包括信澳新能源产业股票、广发制造业精选混合A、南方中 证1000ETF、信澳智远三年持有期混合A、广发大盘成长混合等。本期较上一季未再披露的公募基金共 计8个，主要包括东方红睿泽三年持有混合A、海富通改革驱动混合、中欧小盘成长混合A、南方通元6 个月持有债券A、南方睿阳稳健添利6个月持有债券A等。 2025年4月24日，弘亚数控(002833.SZ)发布2024年年度报告。截至2025年4月23日，共有138个机 ...

2025年4月23日，匠心家居(301061.SZ)发布2024年年度报告。截至2025年4月22日，共有257个机构投资 者披露持有匠心家居A股股份，合计持股量达7783.70万股，占匠心家居总股本的46.51%。其中，前十 大机构投资者包括宁波梅山保税港区随遇心蕊投资有限公司、宁波明明白白企业管理合伙企业(有限合 伙)、香港中央结算有限公司、常州清庙之器企业管理咨询合伙企业(有限合伙)、中国工商银行股份有限 公司-中欧时代先锋股票型发起式证券投资基金、中国工商银行股份有限公司-易方达价值精选混合型证 券投资基金、中国银行股份有限公司-宝盈核心优势灵活配置混合型证券投资基金、浙商银行股份有限 公司-博时凤凰领航混合型证券投资基金、中信证券资产管理(香港)有限公司-客户资金、上海浦东发展 银行股份有限公司-永赢消费主题灵活配置混合型证券投资基金，前十大机构投资者合计持股比例达 36.84%。相较于上一季度，前十大机构持股比例合计下跌了0.76个百分点。 公募基金方面，本期较上一期持股增加的公募基金共计8个，主要包括宝盈核心优势混合A、中欧时代 先锋股票A、永赢稳健增强债券A、博时凤凰领航混合A、华泰柏瑞消费成 ...

Group 1 - Jilin Aodong (000623.SZ) reported its 2024 annual results on April 23, 2025, with 235 institutional investors holding a total of 414 million shares, representing 34.58% of the total share capital [1] - The top ten institutional investors collectively hold 31.95% of the shares, with a decrease of 6.05 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, one public fund increased its holdings, while eight funds decreased their holdings, with a reduction rate of 0.33% [2] - A total of 219 new public funds were disclosed this period, including several major ETFs [2] - One foreign fund, Hong Kong Central Clearing Limited, reduced its holdings by 0.31% compared to the previous quarter [2]

Group 1 - The core viewpoint of the news is that OrbiMed (688322.SH) has reported its annual results for 2024, highlighting significant institutional investor interest and changes in shareholding patterns [1] Group 2 - As of April 21, 2025, a total of 206 institutional investors disclosed holdings in OrbiMed A-shares, with a total shareholding of 127 million shares, accounting for 31.65% of the total share capital [1] - The top ten institutional investors include Shanghai Yunxin Venture Capital Co., Ltd., Zhuhai OrbiMed Investment Partnership (Limited Partnership), and others, with their combined shareholding ratio reaching 26.51% [1] - Compared to the previous quarter, the combined shareholding ratio of the top ten institutions decreased by 3.09 percentage points [1] Group 3 - In the public fund sector, four public funds reported a decrease in holdings compared to the previous quarter, including Bank of China Securities Advantage Manufacturing Stock A and others, with a slight decline in the proportion of reduced holdings [2] - A total of 193 new public funds were disclosed this period, including several funds such as Xingquan Helun Mixed A and others [2] - One public fund, Tianhong Guozheng 2000 Index Enhanced A, was not disclosed in this period compared to the previous quarter [2]

Group 1 - The core viewpoint of the news is the disclosure of shareholding information for Xingqi Eye Pharmaceutical (300573.SZ) as of April 21, 2025, highlighting the involvement of institutional investors and changes in their holdings [1] - A total of 319 institutional investors disclosed holding shares in Xingqi Eye Pharmaceutical, with a combined holding of 33.143 million shares, representing 18.91% of the total share capital [1] - The top ten institutional investors collectively hold 10.85% of the shares, with a decrease of 4.93 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, there was an increase in holdings from one public fund, Dacheng CSI 500 Index Enhanced A, while 12 public funds reduced their holdings, with a decrease rate of 1.35% [2] - A total of 290 new public funds were disclosed this period, including Southern CSI 500 ETF and Huaxin ChiNext 50 ETF [2] - From the pension fund perspective, one pension fund, the Basic Pension Insurance Fund 160222 Combination, reduced its holdings by 1.0% [2] - One foreign fund, Hong Kong Central Clearing Limited, also reduced its holdings by 0.62% [2]

Group 1 - The core viewpoint of the news is the disclosure of institutional and fund holdings in Zhenyu Technology, indicating a significant presence of institutional investors in the company [1][2] - As of April 21, 2025, a total of 105 institutional investors hold shares in Zhenyu Technology, with a combined holding of 22.34 million shares, representing 20.79% of the total share capital [1] - The top ten institutional investors account for 16.23% of the total shares, with a decrease of 1.62 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, 93 new public funds have disclosed holdings in Zhenyu Technology, including notable funds such as Yongying Advanced Manufacturing Selected Mixed Fund A and GF Small and Medium Cap Selected Mixed Fund A [2] - There are 5 public funds that have not disclosed holdings in the current period, including Huashang Quantitative Progress Mixed Fund and Nuon An Hengxin Mixed Fund [2] - One new social security fund, the National Social Security Fund 104 Portfolio, has disclosed holdings in Zhenyu Technology [2] - The foreign investment perspective shows that one foreign institution, Hong Kong Central Clearing Limited, has not disclosed holdings in the current period [2]

Group 1 - The core viewpoint of the news is the disclosure of the 2024 annual report by Guocera Materials (300285.SZ), highlighting the significant institutional ownership and changes in shareholding among public funds and foreign investors [1][2] Group 2 - As of April 21, 2025, a total of 276 institutional investors hold shares in Guocera Materials, with a combined holding of 357 million shares, representing 35.84% of the total share capital [1] - The top ten institutional investors account for 25.94% of the total shares, with a decrease of 1.33 percentage points compared to the previous quarter [1] - In the public fund sector, two funds increased their holdings, while 24 funds reduced their holdings, with a total reduction of 1.81% [2] - A total of 244 new public funds were disclosed this period, while 8 funds were not disclosed compared to the previous quarter [2] - Foreign investment sentiment shows a decrease in holdings from one foreign fund, Hong Kong Central Clearing Limited, with a reduction of 0.39% [2]

Group 1 - The core viewpoint of the news is that Zhangyuan Tungsten Industry (002378.SZ) has reported a decrease in institutional holdings, with the top ten institutional investors holding a combined 63.85% of shares, down 2.33 percentage points from the previous quarter [1] - As of April 21, 2025, a total of 68 institutional investors disclosed holdings in Zhangyuan Tungsten Industry, amounting to 774 million shares, which represents 64.40% of the total share capital [1] Group 2 - In the public fund sector, two public funds reported a decrease in holdings, with a total reduction of 0.15% compared to the previous quarter [2] - A total of 61 new public funds were disclosed this period, including several notable funds such as Yinhua Xinjia Two-Year Holding Mixed Fund and Huaxia CSI 1000 ETF [2] - One pension fund reported a decrease in holdings, specifically the Basic Pension Insurance Fund 804 Combination, with a slight decline in holding percentage [2] - One foreign fund, Hong Kong Central Clearing Limited, also reported a decrease in holdings, with a reduction of 0.40% compared to the previous quarter [2]

公募基金方面本期较上一季度持股减少的公募基金共计1个，即华安宏利混合A，持股减少占比达 0.77%。本期较上一季度新披露的公募基金共计207个，主要包括中信证券卓越成长A、富国中证价值 ETF、广发多因子混合、睿远稳益增强30天持有债券A、大摩领先优势混合等。本期较上一季未再披露 的公募基金共计6个，主要包括前海开源公用事业股票、前海开源新经济混合A、前海开源新兴产业混 合A、华安产业趋势混合A、华安品质领先混合A等。 外资态度来看，本期较上一期持股增加的外资基金共计1个，即香港中央结算有限公司，持股增加占比 达1.01%。 2025年4月21日，炬华科技(300360.SZ)发布2024年年度报告。截至2025年4月20日，共有211个机构投资 者披露持有炬华科技A股股份，合计持股量达1.41亿股，占炬华科技总股本的27.47%。其中，前十大机 构投资者包括杭州炬华集团有限公司、香港中央结算有限公司、中信证券-中信银行-中信证券卓越成长 两年持有期混合型集合资产管理计划、富国中证价值ETF、广发多因子混合、睿远稳益增强30天持有债 券A、大摩领先优势混合、鹏华成长智选混合A、华夏中证红利质量ETF、中证20 ...

Group 1 - The core viewpoint of the news is that TuoJing Life (300642.SZ) has disclosed its annual report for 2024, revealing significant changes in institutional and foreign investment holdings [1] - As of April 19, 2025, a total of 42 institutional investors hold shares in TuoJing Life, with a combined holding of 36.8578 million shares, accounting for 22.61% of the total share capital [1] - The top ten institutional investors collectively hold 22.38% of the shares, which represents a decrease of 5.93 percentage points compared to the previous quarter [1] Group 2 - In terms of public funds, 36 new public funds have been disclosed this period compared to the previous quarter, including several notable funds such as the Medical Device ETF and the West China Quantitative Growth Mixed A [1] - Regarding foreign investment, only one foreign fund, UBS AG, has reduced its holdings, with a decrease of 0.31% [2] - Several foreign institutions, including MERRILL LYNCH INTERNATIONAL and Goldman Sachs, have not disclosed their holdings this period [2]